Breast Cancer

Tremendous progress has been made in the treatment landscape for HER2-positive breast cancer that has significantly altered and improved the outlook for this patient population.

A study assessing the efficacy of pembrolizumab met a key secondary endpoint of extending OS, in combination with chemotherapy, among patients with high-risk early-stage triple-negative breast cancer, according to the agent’s manufacturer.

American Cancer Society has awarded $28 million in new extramural discovery science research and career development grants to fund investigators across several U.S. institutions beginning in July 2024.

CHICAGO — The majority of young breast cancer survivors who attempted pregnancy became pregnant, according to prospective study results scheduled for presentation at ASCO Annual Meeting.

A once-weekly basal insulin provided noninferior HbA1c reductions compared with once-daily insulins in adults with type 2 diabetes who had never taken insulin as well as those who received multiple daily insulin injections, phase 3 data show.

Most childhood cancer survivors are not up to date on guideline-recommended screening for late effects of cancer treatment or second malignancies, according to study results.

Several women oncologists will be honored during this year’s ASCO Annual Meeting.

The gap in cancer mortality between Black and white individuals shrunk dramatically during the past 3 decades, according to a new report.

Women with obesity who undergo bariatric surgery and have higher levels of insulin have a lower risk for breast cancer than women who do not undergo surgery, according to findings published in JAMA Surgery.

Metabolic syndrome scores and obesity appeared linked in different ways to breast cancer incidence and mortality among postmenopausal women, according to findings published in Cancer.